Clinical trial
Study Evaluating SCA-136 Tolerability With Dose Titration and Food
NCT00420706 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00420706 |
|---|---|
| Title | Study Evaluating SCA-136 Tolerability With Dose Titration and Food |
| Official title | A Multi-Dose, Double-Blind, Parallel-Group Study of the Effects of Dose Titration and Administration With Food on the Tolerability of SCA-136 in Healthy Subjects |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | SCA-136 |
| Enrollment | 120 |
| Start date | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Jan 11, 2007 |
| Last update posted | Dec 10, 2007 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: